Clinical and laboratory features of patients with CLL
Patient no. . | Sex . | Age, y . | Rai stage . | ZAP70* . | FISH† . | TP53 . |
---|---|---|---|---|---|---|
1 | F | 82 | 1 | Absent/low | 13q− | Mut (exon V) |
2 | M | 66 | 4 | Interm/high | ND | WT |
3 | M | 65 | 1 | Absent/low | Nor | WT |
4 | M | 68 | 4 | Interm/high | 12+ | WT |
5 | F | 62 | 0 | Absent/low | Nor | WT |
6 | M | 64 | 1 | Absent/low | 13q−/11q− | WT |
7 | M | 67 | 2 | Interm/high | 17p− | WT |
8 | F | 78 | 2 | Absent/low | 11q− | WT |
9 | M | 51 | 0 | Absent/low | Nor | WT |
10 | F | 59 | 0 | Absent/low | Nor | WT |
11 | M | 69 | 2 | Absent/low | 13q−/17p− | WT |
12 | M | 40 | 4 | Interm/high | 11q− | WT |
13 | M | 74 | 2 | Interm/high | 13q− | WT |
14 | M | 62 | 4 | Interm/high | 17p− | WT |
15 | M | 62 | 0 | Absent/low | 11q− | WT |
16 | M | 69 | 2 | Absent/low | 17p− | Mut (exon VII) |
17 | F | 79 | 3 | Absent/low | 12+ | WT |
18 | M | 61 | 2 | Interm/high | 17p− | WT |
19 | M | 63 | 4 | Absent/low | 13q− | WT |
20 | M | 60 | 4 | Absent/low | 17p− | WT |
21 | M | 59 | 2 | Absent/low | 13q− | WT |
22 | M | 64 | 1 | Interm/high | 13q− | WT |
23 | M | 57 | 1 | Absent/low | 12+ | WT |
24 | M | 67 | 4 | ND | ND | WT |
25 | F | 68 | 2 | Interm/high | 17p− | Mut (exon V) |
26 | F | 55 | 0 | Absent/low | ND | WT |
27 | M | 61 | 2 | Absent/low | 17p− | Mut (exon VI) |
Patient no. . | Sex . | Age, y . | Rai stage . | ZAP70* . | FISH† . | TP53 . |
---|---|---|---|---|---|---|
1 | F | 82 | 1 | Absent/low | 13q− | Mut (exon V) |
2 | M | 66 | 4 | Interm/high | ND | WT |
3 | M | 65 | 1 | Absent/low | Nor | WT |
4 | M | 68 | 4 | Interm/high | 12+ | WT |
5 | F | 62 | 0 | Absent/low | Nor | WT |
6 | M | 64 | 1 | Absent/low | 13q−/11q− | WT |
7 | M | 67 | 2 | Interm/high | 17p− | WT |
8 | F | 78 | 2 | Absent/low | 11q− | WT |
9 | M | 51 | 0 | Absent/low | Nor | WT |
10 | F | 59 | 0 | Absent/low | Nor | WT |
11 | M | 69 | 2 | Absent/low | 13q−/17p− | WT |
12 | M | 40 | 4 | Interm/high | 11q− | WT |
13 | M | 74 | 2 | Interm/high | 13q− | WT |
14 | M | 62 | 4 | Interm/high | 17p− | WT |
15 | M | 62 | 0 | Absent/low | 11q− | WT |
16 | M | 69 | 2 | Absent/low | 17p− | Mut (exon VII) |
17 | F | 79 | 3 | Absent/low | 12+ | WT |
18 | M | 61 | 2 | Interm/high | 17p− | WT |
19 | M | 63 | 4 | Absent/low | 13q− | WT |
20 | M | 60 | 4 | Absent/low | 17p− | WT |
21 | M | 59 | 2 | Absent/low | 13q− | WT |
22 | M | 64 | 1 | Interm/high | 13q− | WT |
23 | M | 57 | 1 | Absent/low | 12+ | WT |
24 | M | 67 | 4 | ND | ND | WT |
25 | F | 68 | 2 | Interm/high | 17p− | Mut (exon V) |
26 | F | 55 | 0 | Absent/low | ND | WT |
27 | M | 61 | 2 | Absent/low | 17p− | Mut (exon VI) |